255 related articles for article (PubMed ID: 26524567)
1. Diagnosis of Amelanotic Lentigo Maligna by Using In vivo Reflectance Confocal Microscopy.
Alani A; Ramsay B; Ahmad K
Acta Derm Venereol; 2016 Mar; 96(3):406-7. PubMed ID: 26524567
[No Abstract] [Full Text] [Related]
2. Amelanotic lentigo maligna managed with topical imiquimod.
Lapresta A; García-Almagro D; Sejas AG
J Dermatol; 2012 May; 39(5):503-5. PubMed ID: 21973079
[No Abstract] [Full Text] [Related]
3. Failed treatment of amelanotic lentigo maligna with imiquimod followed by pigment production.
Martires KJ; Capaldi L; Pattee SF; Maloney ME; Bordeaux JS
Arch Dermatol; 2010 Sep; 146(9):1047-8. PubMed ID: 20855714
[No Abstract] [Full Text] [Related]
4. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
[No Abstract] [Full Text] [Related]
5. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE
Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150
[No Abstract] [Full Text] [Related]
7. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
Micantonio T; Fargnoli MC; Peris K
Arch Dermatol; 2006 Apr; 142(4):530-1. PubMed ID: 16618884
[No Abstract] [Full Text] [Related]
8. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
Powell AM; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
[TBL] [Abstract][Full Text] [Related]
9. Image in clinical medicine. Lentigo maligna.
Noel B; Kunzle N
N Engl J Med; 2005 Nov; 353(20):2176. PubMed ID: 16291987
[No Abstract] [Full Text] [Related]
10. Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod.
Ramsdell AM; Zeitouni N
Dermatol Surg; 2009 Feb; 35(2):287-90. PubMed ID: 19215272
[No Abstract] [Full Text] [Related]
11. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs T; van Doorn R; Kirtschig G
Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
[No Abstract] [Full Text] [Related]
12. [Imiquimod in the treatment of lentigo maligna].
Nagore E; Botella-Estrada R
Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
[No Abstract] [Full Text] [Related]
13. Amelanotic lentigo maligna and amelanotic lentigo maligna melanoma: a report of three cases mimicking intraepidermal squamous carcinoma.
Allan SJ; Dicker AJ; Tidman MJ; McLaren KM; Hunter JA
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):78-81. PubMed ID: 9731974
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Melanocyte Density Counts in Topical Imiquimod-Treated Skin Surrounding Lentigo Maligna vs Control Biopsy Specimens.
Flores S; Luby NJ; Bowen GM
JAMA Dermatol; 2018 Apr; 154(4):482-484. PubMed ID: 29453870
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
Woodmansee CS; McCall MW
Dermatol Surg; 2009 Aug; 35(8):1286-9. PubMed ID: 19438661
[No Abstract] [Full Text] [Related]
16. Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study.
Gautschi M; Oberholzer PA; Baumgartner M; Gadaldi K; Yawalkar N; Hunger RE
J Am Acad Dermatol; 2016 Jan; 74(1):81-87.e1. PubMed ID: 26601565
[TBL] [Abstract][Full Text] [Related]
17. Topical 5% imiquimod in the treatment of lentigo maligna.
Wong JG; Toole JW; Demers AA; Musto G; Wiseman MC
J Cutan Med Surg; 2012; 16(4):245-9. PubMed ID: 22784516
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment of lentigo maligna melanoma with imiquimod 5% cream.
Borucki U; Metze D
Dermatology; 2003; 207(3):326-8. PubMed ID: 14571081
[No Abstract] [Full Text] [Related]
19. Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment.
Nadiminti H; Scope A; Marghoob AA; Busam K; Nehal KS
Dermatol Surg; 2010 Feb; 36(2):177-84. PubMed ID: 20039914
[No Abstract] [Full Text] [Related]
20. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
[No Abstract] [Full Text] [Related]
[Next] [New Search]